tirzepatide producer equally effective for early-onset or later-onset type 2 diabetes Who Makes Mounjaro? The Innovators

The standard starting dose is 2.5 mg administered as a once-weekly injection

Based on Sunlight.coms survey of 2,000 U.S

2 Confirm with HR whether your employer's plan includes the anti-obesity benefit Even if your SummaCare plan type generally covers weight-loss GLP-1s, the benefit is only available if your employer purchased it

Persistent high blood sugar (hyperglycemia) can lead to conditions rooted in insulin resistance like pre-diabetes or type 2 diabetes, which then increases the risk of nerve damage and eye disease

This information helps your provider make informed decisions about your treatment plan

That year 390 million children and adolescents aged 5-19 were thought to be overweight, of whom 160 million were obese (WHO 2024)